---
title: "KinLong announced its performance for the first three quarters, with a net profit attributable to the parent company of 16.5603 million yuan, a decrease of 49.61%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263548263.md"
description: "According to the Zhitong Finance APP, KinLong released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 4.297 billion yuan, a year-on-year decrease of 12.50%. The net profit attributable to shareholders of the listed company was 16.5603 million yuan, a year-on-year decrease of 49.61%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 2.6264 million yuan. The basic earnings per share were 0.05 yuan"
datetime: "2025-10-30T14:21:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263548263.md)
  - [en](https://longbridge.com/en/news/263548263.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263548263.md)
---

# KinLong announced its performance for the first three quarters, with a net profit attributable to the parent company of 16.5603 million yuan, a decrease of 49.61%

According to the Zhitong Finance APP, KinLong (002791.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 4.297 billion yuan, a year-on-year decrease of 12.50%. The net profit attributable to shareholders of the listed company was 16.5603 million yuan, a year-on-year decrease of 49.61%. The net loss attributable to shareholders of the listed company, after deducting non-recurring gains and losses, was 2.6264 million yuan. The basic earnings per share were 0.05 yuan

### Related Stocks

- [002791.CN](https://longbridge.com/en/quote/002791.CN.md)

## Related News & Research

- [ZAWYA: Al Habtoor Tower: Dubai's boldest residential project yet](https://longbridge.com/en/news/287051508.md)
- [Trump Delivers Confused Rambling After Claiming ’Every Agency' Has 'Scum'](https://longbridge.com/en/news/287086760.md)
- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Orkla (OB:ORK) Margin Improvement Challenges Cautious Earnings Narratives Heading Into Q1 2026](https://longbridge.com/en/news/287134604.md)
- ['Am I out?' Drought and rising costs from Iran war deepen pain for US farmers](https://longbridge.com/en/news/287042948.md)